Ibutilide

DRUG6 trials

Sponsors

Vivek Reddy, Indiana University

Conditions

Abnormalities, Drug-InducedAtrial FibrillationLong QT SyndromePersistent Atrial FibrillationProlonged QT Interval in EKG and Sudden Death

Phase 2

Influence of Progesterone Administration on Drug-Induced QT Interval Lengthening

CompletedNCT01929083

Indiana UniversityProlonged QT Interval in EKG and Sudden Death

Start: 2013-04-30End: 2014-06-30Updated: 2015-10-30

Phase 4

Influence of Testosterone Administration on Drug-Induced QT Interval Prolongation and Torsades de Pointes

CompletedNCT02513940

Indiana UniversityLong QT Syndrome

Start: 2016-05-31End: 2017-10-19Updated: 2019-08-28

Reducing the Risk of Drug-Induced QT Interval Lengthening in Women

CompletedNCT03834883

Indiana UniversityAbnormalities, Drug-Induced, Long QT Syndrome

Start: 2019-03-26End: 2024-05-23Updated: 2025-07-01

Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening

CompletedNCT04675788

Indiana UniversityAbnormalities, Drug-Induced, Long QT Syndrome

Start: 2021-09-02End: 2025-04-16Updated: 2026-03-19

Unknown Phase

Modified Ablation Guided by Ibutilide Use in Chronic Atrial Fibrillation

CompletedNCT01014741

Vivek ReddyPersistent Atrial Fibrillation

Start: 2009-10-31End: 2015-01-31Updated: 2018-02-14

ECGi Ibutilide: Effect of Ibutilide on AF Source Location and Organization

TerminatedNCT03370536

Vivek ReddyAtrial Fibrillation, Persistent Atrial Fibrillation

Start: 2017-11-01End: 2018-07-18Updated: 2020-02-10

Related Papers

Termination of persistent atrial fibrillation during pulmonary vein isolation: insight from the MAGIC-AF trial.

2017-10-019 citations

The modified stepwise ablation guided by low-dose ibutilide in chronic atrial fibrillation trial (The MAGIC-AF Study)

European Heart Journal2016-02-0420 citations